News

CVS Health CVS ... 2025 roadmap offer potential pathways to recovery. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Truist Financial analyst David S Macdonald maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $82.00. The company’s shares closed yesterday at ...